ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1604

Parity and the Risk of Developing Rheumatoid Arthritis: Results From the Swedish Epidemiological Investigation of Rheumatoid Arthritis Study

Cecilia Orellana1, Lars Klareskog2, Lars Alfredsson1 and Camilla Bengtsson1, 1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 2Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: anti-citrullinated protein/peptide antibodies (ACPA), pregnancy and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research II: Epidemiologic Risk Factors in the Development of Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is more common among women than among men and the gender difference in incidence seems to be most striking before menopause (1). The importance of hormonal/reproductive factors has been hypothesized to explain this difference, but the literature is scarce and contradictory. Parity has been suggested to decrease the risk of RA and postpone the disease onset but, on the contrary, a higher risk of RA in the post-partum period has been described (2). The aim of this work was to study the association between parity, post-partum period and age at first birth and the risk of developing RA in pre-menopausal women, by stratifying the cases according to presence/absence of antibodies to citrullinated peptides (ACPA).

Methods: Data from the Swedish population-based EIRA (Epidemiological Investigation of RA) case-control study comprising 603 incident cases aged 18-44 years old women and 906 controls (matched by age and residential area) was analyzed. Parity, post-partum period before the onset of symptoms and age at first birth were assessed by means of an identical questionnaire answered by the participants. In all analyses, nulliparous women were used as the reference group. Unconditional logistic regression analyses to obtain odds ratios (ORs) with 95% confidence intervals (CI) were performed.

Results: An increased risk of developing ACPA-negative RA in parous women compared with nulliparous women (OR 2.1 (95% CI 1.4-3.2)) was found. Women whose most recent delivery occurred the same year as the disease onset showed an increased risk of developing ACPA-negative RA (OR 2.6 (95% CI 1.4-4.7)). This risk decreased after 1 year (OR 1.8 (95% CI 0.9-3.6)) and reached the null value after 2 years (p-value for trend 0.0147). Women who delivered their first child at a younger age had an increased risk of developing ACPA-negative RA (p-value for trend 0.0158). No association between parity, post-partum period or age at first birth and the risk of ACPA-positive RA was observed.

Conclusion: Our results indicate that parity increases the risk of ACPA-negative RA in pre-menopausal women, but has no association with ACPA-positive RA. The increased risk seemed to be more pronounced in the post-partum period within 1 year after child delivery and among women who had their first child at young age. As previously described, a postponed onset of RA, comparable with the amelioration of the pre-established disease in pregnant women followed by a post-partum flare-up might explain these results in regards to the post-partum period. Further research is needed in order to explore the biological mechanisms behind our findings but the effect of hormonal/reproductive factors such as parity might partly explain the higher incidence of RA in pre-menopausal women.

References

1. Doran, M.F., et al., Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum, 2002. 46(3): p. 625-31.

2. Wallenius, M., et al., Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry. Ann Rheum Dis, 2010. 69(2): p. 332-6.


Disclosure:

C. Orellana,
None;

L. Klareskog,
None;

L. Alfredsson,
None;

C. Bengtsson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/parity-and-the-risk-of-developing-rheumatoid-arthritis-results-from-the-swedish-epidemiological-investigation-of-rheumatoid-arthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology